No one understands technology like Twitter and Square CEO Jack Dorsey.
That’s according to Nate Checketts, co-founder and head of smart apparel maker Rhone, who got a chance to spend some time with the tech exec over the course of a year.
“We started talking about wearable technology, and he said something that really stuck with me. Technology is something that should really fade into the background,” Checketts said in an interview on Cheddar Monday. “If it’s done well...you shouldn’t even have to think that you’re wearing it.”
Checketts said he’s carried this mindset with him when Rhone designed its GoldFusion line. The technology infuses nanoparticles of gold with fabric.
Rhone claims that GoldFusion allows its brand to absorb liquid three times faster than the industry standard and says that it remains 99 percent effective even after 100 washes.
“The technology is doing its work without you having to do anything,” he told “Opening Bell.” “With this, it just works. You put it on and it works” he said.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
